论文部分内容阅读
目的探讨小儿腹泻治疗中药物联合应用的安全性及有效性。方法选择本院2011年1月~2012年12月间收治的腹泻患儿120例作为研究对象,120例患儿随机分为对照组和治疗组,对照组单纯采用蒙脱石散进行治疗,治疗组在此基础上联合双岐三联活菌片口服,观察治疗过程中患儿不良反应及治疗效果。结果治疗组有效率达到91.67%,对照组总有效率68.33%,治疗组疗效显著优于对照组(P<0.05),两组患者治疗中均无不良反应发生。结论蒙脱石散联合双岐三联活菌片治疗小儿腹泻安全可靠,疗效显著,可作为临床推广应用。
Objective To investigate the safety and efficacy of the combined application of drugs in children with diarrhea. Methods A total of 120 children with diarrhea admitted to our hospital from January 2011 to December 2012 were selected as the research object. 120 children were randomly divided into control group and treatment group. The control group was treated with montmorillonite powder alone, On the basis of this group, the patients were treated orally with Bifidobacterium trifoliatum and observed the adverse reaction and treatment effect in children. Results The effective rate was 91.67% in the treatment group and 68.33% in the control group. The curative effect in the treatment group was significantly better than that in the control group (P <0.05). No adverse reactions occurred in the two groups. Conclusion Combined montmorillonite powder and Bifido triple active bacterium tablets in the treatment of children with diarrhea is safe and reliable, and has a significant curative effect. It can be used as a clinical application.